Davern Capital Partners, LP
NY, NY · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 12, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$514.1M2026 Q3
Positions17
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.81.3%
What Changed This Quarter?
Top Holdings
BNTX
BioNTech
13.0%
RPRX
Royalty Pharma
11.1%
INSM
Insmed
11.0%
ROIV
Roivant Sciences
10.5%
IONS
Ionis Pharmaceuticals
9.4%
ARGX
Argenx
7.0%
REGN
Regeneron Pharmaceuticals
6.0%
NTRA
Natera
5.1%
Read the 2026-Q2 quarterly report · 13F Filing Calendar
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.